Half-fluence photodynamic Therapy in acute central serous Chorioretinopathy

Retina

Volumn 32, Issue 10, 2012, Pages 2014-2019

  Smretschnig, Eva ^a,b   Ansari Shahrezaei, Siamak ^a,b,c,d   Moussa, Sarah ^a   Glittenberg, Carl ^a,b   Krebs, Ilse ^a,b   Binder, Susanne ^a,b,d  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d Retina Center Vienna   (Austria)

Author keywords

Central serous chorioretinopathy; Indocyanine green angiography; Photodynamic therapy

Indexed keywords

VERTEPORFIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; FEMALE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; PHOTODYNAMIC THERAPY; RECURRENT DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; TREATMENT OUTCOME; VISUAL ACUITY;

ACUTE DISEASE; ADULT; AGED; CENTRAL SEROUS CHORIORETINOPATHY; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84871275443     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318242b9ab     Document Type: Article

References (27)

1. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:1-139.
2. Gass JD. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol 1. 4th ed. St. Louis, MO: Mosby; 1997: 52-70.
3. Han DP, Thompson HS, Folk JC. Differentiation between recently resolved optic neuritis and central serous retinopathy. Use of tests of visual function. Arch Ophthalmol 1985;103: 394-396.
4. Chan WM, Lai TY, Lai RY, et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 2008;28:85-93.
5. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-242.
6. Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 2008;115:1756-1765.
7. Ober MD, Yannuzzi LA, Do DV, et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology 2005;112: 2088-2094.
8. Wu ZH, Lai RY, Yip YW, et al. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy. A randomized placebo-controlled trial. Retina 2011;31:1378-1386.
9. Zhao MW, Zhou P, Xiao HX, et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin. Retina 2009;29:1155-1161.
10. Reibaldi M, Cardascia N, Longo A, et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol 2010;149:307-315.
11. Ansari-Shahrezaei S, Ergun E, Stur M. The effect of digital measurement software on photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006;244:137-142.
12. Ansari-Shahrezaei S, Binder S, Stur M. The effect of laser unit on photodynamic therapy spot size. Graefes Arch Clin Exp Ophthalmol 2011;249:11-14.
13. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010;149:441-466.
14. Kondo M, Ito Y, Miyata K, et al. Effect of axial length on laser spot size during photodynamic therapy: an experimental study in monkeys. Am J Ophthalmol 2006;141:214-215.
15. Ansari-Shahrezaei S, Ergun E, Stur M. The effect of axial length on photodynamic therapy. Am J Ophthalmol 2006; 141:699-702.
16. Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration. 2-year results of a randomized clinical trial. Arch Ophthalmol 2005;123:448-457.
17. Burumcek E, Mudun A, Karacorlu S, Arslan MO. Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 1997;104:616-622.
18. Robertson DM. Argon laser photocoagulation treatment in central serous chorioretinopathy. Ophthalmology 1986;93: 972-974.
19. Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983;95:457-466.
20. Kitzmann AS, Pulido JS, Diehl NN, et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology 2008;115:169-173.
21. Klatt C, Saeger M, Oppermann T, et al. Selective retina therapy for acute central serous chorioretinopathy. Br J Ophthalmol 2011;95:83-88.
22. Golshahi A, Klingmüller D, Holz FG, Eter N. Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study. Acta Ophthalmol 2010;88:576-581.
23. Lim JW, Kim MU. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2010;249:969-974.
24. Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003; 87:1453-1458.
25. Colucciello M. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. Retina 2006;26:239-242.
26. Shinojima A, Kawamura A, Mori R, et al. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Retina 2011;31:1912-1920.
27. Reibaldi M, Boscia F, Avitabile T, et al. Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 2011;151:953-960.